rhNELL-1 Growth Factor

Bone Biologics Release: New Preclinical Data For Spine Fusion Demonstrates Osteopromotive Properties

December 20, 2017 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corp. (OTC QB: BBLG), a developer of orthobiologic products for the spinal fusion,…